Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term randomized-trial. Found 54 abstracts

no pagination
Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ. A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E-2 in Patients With Barrett's Esophagus. Gastroenterology. 2012 Oct;143(4):917-U91.   PMCID: PMC3458136
Freedman GM, Anderson PR, Bleicher RJ, Litwin S, Li TY, Swaby RF, Ma CM, Li JS, Sigurdson ER, Watkins-Bruner D, Morrow M, Goldstein LJ. Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(4):888-93.   PMCID: PMC3419789
Hoppe RT, Advani RH, Ai WY, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H. Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2012 May;10(5):589-97.   PMCID: not NIH funded
Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer. Annals of Surgical Oncology. 2012 May;19(5):1508-16.   PMCID: not NIH funded
Keller LM, Sopka DM, Li TY, Klayton T, Li JS, Anderson PR, Bleicher RJ, Sigurdson ER, Freedman GM. Five-year Results of Whole Breast Intensity Modulated Radiation Therapy for the Treatment of Early Stage Breast Cancer: The Fox Chase Cancer Center Experience. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(4):881-7.
LaCasce AS, Vandergrift JL, Rodriguez MA, Abel GA, Crosby AL, Czuczman MS, Nademanee AP, Blayney DW, Gordon LI, Millenson M, Vanderplas A, Lepisto EM, Zelenetz AD, Niland J, Friedberg JW. Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database. Blood. 2012 Mar;119(9):2093-9.   PMCID: not NIH funded
Ma GX, Yin LH, Gao WZ, Tan Y, Liu R, Fang C, Ma XS. Workplace-Based Breast Cancer Screening Intervention in China. Cancer Epidemiology Biomarkers & Prevention. 2012 Feb;21(2):358-67.   PMCID: not NIH funded
Urban N, Thorpe J, Karlan BY, McIntosh MW, Palomares MR, Daly MB, Paley P, Drescher CW. Interpretation of Single and Serial Measures of HE4 and CA125 in Asymptomatic Women at High Risk for Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 2012 Nov;21(11):2087-94.   PMCID: PMC3493821
Wai CJ. Axillary Anatomy and History. Current Problems in Cancer. 2012 Sep;36(5):234-44.   PMCID: Not NIH Funded
Wilder RB, Buyyounouski MK, Efstathiou JA, Beard CJ. Radiotherapy Treatment Planning for Testicular Seminoma. International Journal of Radiation Oncology Biology Physics. 2012 Jul;83(4):E445-E452.   PMCID: not NIH funded
Xu QY, Chen Y, Grimm J, Fan JJ, An LL, Xue JY, Pahlajani N, LaCouture T. Dosimetric investigation of accelerated partial breast irradiation (APBI) using CyberKnife. Medical Physics. 2012 Nov;39(11):6621-8.   PMCID: not NIH funded
Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM, Blute ML, Buyyounouski MK. Long-Term Survival After Radical Prostatectomy Versus External-Beam Radiotherapy for Patients With High-Risk Prostate Cancer. Cancer. 2011 Jul;117(3):2883-91.   PMCID: PMC3139725
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M. Myeloid Growth Factors. Journal of the National Comprehensive Cancer Network. 2011 Aug;9(8):914-+.   PMCID: not NIH funded
McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom SS, Beitler JJ, Expert Panel Radiation O. ACR APPROPRIATENESS CRITERIA (R) RETREATMENT OF RECURRENT HEAD AND NECK CANCER AFTER PRIOR DEFINITIVE RADIATION. International Journal of Radiation Oncology Biology Physics. 2011 Aug;80(5):1292-8.   PMCID: not NIH funded
Murphy C, Anderson PR, Li TY, Bleicher RJ, Sigurdson ER, Goldstein LJ, Swaby R, Denlinger C, Dushkin H, Nicolaou N, Freedman GM. IMPACT OF THE RADIATION BOOST ON OUTCOMES AFTER BREAST-CONSERVING SURGERY AND RADIATION. International Journal of Radiation Oncology Biology Physics. 2011 Sep;81(1):69-76.   PMCID: PMC2992091
Plimack ER, Hudes GR. Selecting Targeted Therapies for Patients With Renal Cell Carcinoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):997-1007.   PMCID: not NIH funded
Blay JY, von Mehren M, Blackstein ME. Perspective on Updated Treatment Guidelines for Patients With Gastrointestinal Stromal Tumors. Cancer. 2010 Nov;116(22):5126-37.   PMCID: NIH funded
Freedman GM, Li TY, Anderson PR, Nicolaou N, Konski A. Health states of women after conservative surgery and radiation for breast cancer. Breast Cancer Research and Treatment. 2010 Jun;121(2):519-26.   PMCID: PMCID: PMC2874617 [Available on 2011/6/1]
Gopal RS, Dubey S, Rosenzweig KE, Chang JY, Decker R, Gewanter RM, Kong FM, Lally BE, Langer CJ, Lee HK, Movsas B. ACR APPROPRIATENESS CRITERIA (R) ON INDUCTION AND ADJUVANT THERAPY FOR STAGE N2 NON-SMALL-CELL LUNG CANCER: EXPERT PANEL ON RADIATION ONCOLOGY-LUNG. International Journal of Radiation Oncology Biology Physics. 2010 Nov;78(4):969-74.   PMCID: not NIH funded
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term randomized-trial

randomized-trial carcinoma radiotherapy therapy irradiation trial surgery cancer chemotherapy squamous-cell carcinoma conserving surgery breast-cancer follow-up radiation-therapy quality-of-life surgical adjuvant breast multicenter Appropriateness criteria phase-iii trial Radiation therapy phase-iii fever chemoprevention recommendations nonsteroidal antiinflammatory drugs non-hodgkins-lymphoma efficacy intermediate-risk target volume patients pts chemotherapy-induced european mcl network 2002 rischilles e-v9-p203 interferon-alpha time trends fatigue germ-cell tumors spread conserving surgical-procedures surgical clips tamoxifen progression colony-stimulating factor biochemical failure concurrent chemotherapy lumpectomy superior prospective chemoradiotherapy uk standardization risk 2000 wble b-p189 20-year radical prostatectomy prostate cancer-radiation therapy-androgen-deprivation therapy-prostate-specific antigen fdg-pet renal cell 1987 arlson me-journal of chronic diseases-v40-p373 stem-cell transplantation intensity-modulated radiotherapy korean-american women cervical-cancer internal mammary nodes local recurrences asian women tyrosine-kinase inhibitor antigen era acid salvage surgery guideline dosimetric analysis NCCN Guidelines oncology-group adenocarcinoma lung metastases free survival ursodeoxycholic NCCN Clinical Practice Guidelines Salvage surgery Chemotherapy induced febrile toxicity 20-year follow-up self-examination survivors services task-force international prognostic index 1975 cock sj-biometrics-v31-p103 kidney neoplasms nsclc Reirradiation progression-free survival positron-emission-tomography 1995 evallier b-v13-p1564 pathology involved-field Carcinoma 2006 ng q-building life skills transplantation mortality Breast cancer Breast boost-Hypofractionation-IMRT-Radiation therapy Salvage c-kit 2010 dermott df-v28 sunitinib Radiation therapy Breast cancer-EQ-5D-EuroQol-Health states hormonal-therapy women cell lung-cancer controlled phase-iii 2 cycles metaanalysis stage-i seminoma screening algorithms androgen-deprivation therapy cell-proliferation Chemoradiation genetics IMRT Breast cancer european consensus CyberKnife APBI-planning dose radiation consensus-group egcccg college phase-2 medullary survival Radiation boost 1989 ssa sd-international journal of radiation oncology biology physics-v16-p383 conformal radiation-therapy radiotherapy hypofractionation endocrine therapy hong-kong 1967 rrest apm-proceedings of the royal society of medicine-london-v60-p938 Breast cancer nasopharyngeal carcinoma recurrence prognostic-factors group protocol 92-02 prospective multicenter imatinib mesylate clear cell renal cell carcinoma mesothelin population biomarker panels mammography Field Radiotherapy-Dose-Testicular-Seminoma non-small-cell lung cancer non-clear cell renal cell carcinoma
Last updated on Saturday, July 04, 2020